PTEN M-CBR3, a Versatile and Selective Regulator of Inositol 1,3,4,5,6-Pentakisphosphate (Ins(1,3,4,5,6)P5)

Elaine A. Orchiston, D. Bennett, Nicholas R. Leslie, Rosemary G. Clarke, Lucinda Winward, C. Peter Downes, Stephen T. Safrany

Journal of Biological Chemistry · 2004 · 29 citations · 38 references

DOIFull text

Open access

Concepts

Abstract

The PTEN (phosphatase and tensin homologue deleted on chromosome 10) tumor suppressor is a phosphatidylinositol 3,4,5-trisphosphate (PtdInsP3) 3-phosphatase that plays a crucial role in regulating many cellular processes by antagonizing the phosphoinositide 3-kinase signaling pathway. Although able to metabolize soluble inositol phosphates in vitro, the question of their significance as physiological substrates is unresolved. We show that inositol phosphates are not regulated by wild type PTEN, but that a synthetic mutant, PTEN M-CBR3, previously thought to be inactive toward inositides, can selectively regulate inositol 1,3,4,5,6-pentakisphosphate (Ins(1,3,4,5,6)P5). Transfection of U87-MG cells with PTEN M-CBR3 lowered Ins(1,3,4,5,6)P5 levels by 60% without detectable effect on PtdInsP3. Although PTEN M-CBR3 is a 3-phosphatase, levels of myo-inositol 1,4,5,6-tetrakisphosphate were not increased, whereas myo-inositol 1,3,4,6-tetrakisphospate levels increased by 80%. We have used PTEN M-CBR3 to study the physiological function of Ins(1,3,4,5,6)P5 and have found that Ins(1,3,4,5,6)P5 does not modulate PKB phosphorylation, nor does it regulate clathrin-mediated epidermal growth factor receptor internalization. By contrast, PTEN M-CBR3 expression, and the subsequent lowering of Ins(1,3,4,5,6)P5, are associated with reduced anchorage-independent colony formation and anchorage-dependent proliferation in U87-MG cells. Our results, together with previously published data, suggest that Ins(1,3,4,5,6)P5 has a role in proliferation. The PTEN (phosphatase and tensin homologue deleted on chromosome 10) tumor suppressor is a phosphatidylinositol 3,4,5-trisphosphate (PtdInsP3) 3-phosphatase that plays a crucial role in regulating many cellular processes by antagonizing the phosphoinositide 3-kinase signaling pathway. Although able to metabolize soluble inositol phosphates in vitro, the question of their significance as physiological substrates is unresolved. We show that inositol phosphates are not regulated by wild type PTEN, but that a synthetic mutant, PTEN M-CBR3, previously thought to be inactive toward inositides, can selectively regulate inositol 1,3,4,5,6-pentakisphosphate (Ins(1,3,4,5,6)P5). Transfection of U87-MG cells with PTEN M-CBR3 lowered Ins(1,3,4,5,6)P5 levels by 60% without detectable effect on PtdInsP3. Although PTEN M-CBR3 is a 3-phosphatase, levels of myo-inositol 1,4,5,6-tetrakisphosphate were not increased, whereas myo-inositol 1,3,4,6-tetrakisphospate levels increased by 80%. We have used PTEN M-CBR3 to study the physiological function of Ins(1,3,4,5,6)P5 and have found that Ins(1,3,4,5,6)P5 does not modulate PKB phosphorylation, nor does it regulate clathrin-mediated epidermal growth factor receptor internalization. By contrast, PTEN M-CBR3 expression, and the subsequent lowering of Ins(1,3,4,5,6)P5, are associated with reduced anchorage-independent colony formation and anchorage-dependent proliferation in U87-MG cells. Our results, together with previously published data, suggest that Ins(1,3,4,5,6)P5 has a role in proliferation. PTEN (phosphatase and tensin homologue deleted on chromosome 10) 1The abbreviations used are: PTEN, phosphatase and tensin homologue deleted on chromosome 10; PtdInsP3, phosphatidylinositol 3,4,5-trisphosphate; PtdIns(3)P, phosphatidylinositol 3-phosphate; PtdIns(3,4)P2, phosphatidylinositol 3,4-bisphosphate; PtdIns(3,5)P2, phosphatidylinositol 3,5-bisphosphate; Ins(1,3,4,6)P4, inositol 1,3,4,6-tetrakisphosphate; Ins(1,4,5,6)P4, inositol 1,4,5,6-tetrakisphosphate; Ins(1,3,4,5,6)P5, inositol 1,3,4,5,6-pentakisphosphate; GFP, green fluorescence protein; EGFP, enhanced GFP; FACS, fluorescence-activated cell sorting; PH, pleckstrin homology; PBS, phosphate-buffered saline; PKB, protein kinase B; PLC, phospholipase C; HPLC, high-performance liquid chromatography; InsP6, inositol hexakisphosphate; SHIP, src homology 2 domain-containing inositol phosphatase; MIPP, multiple inositol polyphosphate phosphatase. is a dual specificity phosphatase that is mutated in a wide range of human sporadic tumor types (1.Leslie N.R. Downes C.P. Cell. Signal. 2002; 14: 285-295Crossref PubMed Scopus (354) Google Scholar). The PTEN gene encodes a 403-amino acid protein, which is a member of the protein-tyrosine phosphatase family. However, there have been no good phosphoprotein substrates identified to date. The tumor suppressor function of PTEN relies on its ability to metabolize acidic nonprotein substrates (2.Maehama T. Dixon J.E. J. Biol. Chem. 1998; 273: 13375-13378Abstract Full Text Full Text PDF PubMed Scopus (2614) Google Scholar, 3.Myers M.P. Pass I. Batty I.H. Van der Kaay J. Stolarov J.P. Hemmings B.A. Wigler M.H. Downes C.P. Tonks N.K. Proc. Natl. Acad. Sci. U. S. A. 1998; 95: 13513-13518Crossref PubMed Scopus (1013) Google Scholar). Indeed, PTEN dephosphorylates the signaling molecules, phosphatidylinositol 3-phosphate (PtdIns(3)P), phosphatidylinositol 3,4-bisphosphate (PtdIns(3,4)P2), phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P2), and phosphatidylinositol 3,4,5-trisphosphate (PtdInsP3) in vitro by removal of the phosphate at the 3-position of these substrates. The preferred substrate was found to be PtdInsP3 by a factor of some 200-fold (4.McConnachie G. Pass I. Walker S.M. Downes C.P. Biochem. J. 2003; 371: 947-955Crossref PubMed Scopus (98) Google Scholar). In this respect, PTEN acts as a functional antagonist of phosphoinositide 3-kinase signaling pathways, promoting apoptosis and inhibiting cell-cycle progression (5.Stambolic V. Suzuki A. de la Pompa J.L. Brothers G.M. Mirtsos C. Sasaki T. Ruland J. Penninger J.M. Siderovski D.P. Mak T.W. Cell. 1998; 95: 29-39Abstract Full Text Full Text PDF PubMed Scopus (2120) Google Scholar, 6.Sun H. Lesche R. Li D.M. Liliental J. Zhang H. Gao J. Gavrilova N. Mueller B. Liu X. Wu H. Proc. Natl. Acad. Sci. U. S. A. 1999; 96: 6199-6204Crossref PubMed Scopus (693) Google Scholar, 7.Cheney I.W. Neuteboom S.T. Vaillancourt M.T. Ramachandra M. Bookstein R. Cancer Res. 1999; 59: 2318-2323PubMed Google Scholar). Evidence for this includes a naturally occurring mutation (PTEN G129E), identified in sufferers of Cowden disease, in which patients encounter multiple hamartomatous lesions, especially of the skin, mucous membranes, breast, and thyroid. The PTEN G129E mutant has comparable activity to PTEN against the synthetic phosphoprotein substrate, polyGluTyrP, but is unable to dephosphorylate inositol lipids, indicating that the lipid phosphatase activity and not protein phosphatase activity is required for tumor suppressor function (3.Myers M.P. Pass I. Batty I.H. Van der Kaay J. Stolarov J.P. Hemmings B.A. Wigler M.H. Downes C.P. Tonks N.K. Proc. Natl. Acad. Sci. U. S. A. 1998; 95: 13513-13518Crossref PubMed Scopus (1013) Google Scholar). PTEN has several structural features, including an N-terminal phosphatase domain requiring a reduced cysteine (Cys124), a calcium-independent C2 domain, that has been shown to bind lipid vesicles in vitro, and a sequence shown to bind PDZ domains (see Ref. 1.Leslie N.R. Downes C.P. Cell. Signal. 2002; 14: 285-295Crossref PubMed Scopus (354) Google Scholar). In cells, PTEN exists as a phosphoprotein, with phosphorylation occurring at a region to the C terminus of the C2 domain (8.Torres J. Pulido R. J. Biol. Chem. 2001; 276: 993-998Abstract Full Text Full Text PDF PubMed Scopus (534) Google Scholar, 9.Vazquez F. Ramaswamy S. Nakamura N. Sellers W.R. Mol. Cell. Biol. 2000; 20: 5010-5018Crossref PubMed Scopus (656) Google Scholar). It has recently been shown that the C2 domain, and not the PDZ-binding sequence, plays a crucial role in membrane targeting and substrate specificity (10.Lee J.O. Yang H.J. Georgescu M.M. Di Cristofano A. Maehama T. Shi Y.G. Dixon J.E. Pandolfi P. Pavletich N.P. Cell. 1999; 99: 323-334Abstract Full Text Full Text PDF PubMed Scopus (883) Google Scholar, 11.Leslie N.R. Gray A. Pass I. Orchiston E.A. Downes C.P. Biochem. J. 2000; 346: 827-833Crossref PubMed Scopus (71) Google Scholar, 12.Leslie N.R. Bennett D. Gray A. Pass I. Hoang-Xuan K. Downes C.P. Biochem. J. 2001; 357: 427-435Crossref PubMed Scopus (63) Google Scholar). Functional interference with this C2 domain, exemplified by the artificially modified PTEN M-CBR3 protein first described by Lee et al. (10.Lee J.O. Yang H.J. Georgescu M.M. Di Cristofano A. Maehama T. Shi Y.G. Dixon J.E. Pandolfi P. Pavletich N.P. Cell. 1999; 99: 323-334Abstract Full Text Full Text PDF PubMed Scopus (883) Google Scholar), causes a reduction in the ability to interact with lipid membranes but marginally increases phosphatase activity toward inositol phosphate substrates (4.McConnachie G. Pass I. Walker S.M. Downes C.P. Biochem. J. 2003; 371: 947-955Crossref PubMed Scopus (98) Google Scholar, 10.Lee J.O. Yang H.J. Georgescu M.M. Di Cristofano A. Maehama T. Shi Y.G. Dixon J.E. Pandolfi P. Pavletich N.P. Cell. 1999; 99: 323-334Abstract Full Text Full Text PDF PubMed Scopus (883) Google Scholar). Expression of GFP-tagged PTEN suggests that it is predominantly cytoplasmic, in agreement with most studies utilizing PTEN-selective antibodies (11.Leslie N.R. Gray A. Pass I. Orchiston E.A. Downes C.P. Biochem. J. 2000; 346: 827-833Crossref PubMed Scopus (71) Google Scholar, 13.Gimm O. Perren A. Weng L.P. Marsh D.J. Yeh J.J. Ziebold U. Gil E. Hinze R. Delbridge L. Lees J.A. Mutter G.L. Robinson B.G. Komminoth P. Dralle H. Eng C. Am. J. Pathol. 2000; 156: 1693-1700Abstract Full Text Full Text PDF PubMed Scopus (270) Google Scholar, 14.Perren A. Komminoth P. Saremaslani P. Matter C. Feurer S. Lees J.A. Heitz P.U. Eng C. Am. J. Pathol. 2000; 157: 1097-1103Abstract Full Text Full Text PDF PubMed Scopus (230) Google Scholar). Its role as a lipid phosphatase, however, requires interaction with membranes, such that PTEN M-CBR3 is unable to regulate PtdInsP3 levels, whereas myristoylated PTEN, which is anchored to the membrane, is more effective than PTEN in altering effects downstream of PtdInsP3 (12.Leslie N.R. Bennett D. Gray A. Pass I. Hoang-Xuan K. Downes C.P. Biochem. J. 2001; 357: 427-435Crossref PubMed Scopus (63) Google Scholar, 15.Georgescu M.M. Kirsch K.H. Kaloudis P. Yang H.J. Pavletich N.P. Hanafusa H. Cancer Res. 2000; 60: 7033-7038PubMed Google Scholar). It has recently been suggested that the cellular substrates of PTEN may include inositol phosphates, particularly Ins(1,3,4,5,6)P5 (16.Caffrey J.J. Darden T. Wenk M.R. Shears S.B. FEBS Lett. 2001; 499: 6-10Crossref PubMed Scopus (36) Google Scholar). Therefore, the effects of PTEN could be mediated by regulation of these inositol phosphates. In this study we have clarified the effects of PTEN expression on inositol lipid and inositol phosphate levels in cells. PTEN expression lowered PtdInsP3 and PtdIns(3,4)P2. We found no suggestion that PTEN could be a physiological regulator of inositol phosphates. The PTEN M-CBR3 mutant, however, selectively affected inositol phosphate levels, especially Ins(1,3,4,5,6)P5, without altering the levels of 3-phosphoinositide lipids. With this new insight into the effects of PTEN M-CBR3 we have re-evaluated previously published data in determining the roles played by Ins(1,3,4,5,6)P5 and suggest that Ins(1,3,4,5,6)P5 is a proliferative agent, because lowering its levels correlated with decreased cell growth and anchorage-independent colony formation. Cell Culture—Tissue culture media and additives were provided by Invitrogen. U87-MG cells, obtained from the European Collection of Animal Cell Cultures, were maintained in minimal essential medium, plus 2 mm glutamine, 1% nonessential amino acids, 1 mm sodium pyruvate, and Expression were into the U87-MG cells a previously described for expression (12.Leslie N.R. Bennett D. Gray A. Pass I. Hoang-Xuan K. Downes C.P. Biochem. J. 2001; 357: 427-435Crossref PubMed Scopus (63) Google Scholar). were for cells were of protein were as as of from U87-MG cells GFP-tagged Transfection of U87-MG cells for proliferation was as described were as previously PTEN which was by PTEN G129E and PTEN M-CBR3 with and in and the wild type region of the protein PTEN with that the M-CBR3 The sequence was and was as of and were with in for to in The was with 1 mm and the inositol phosphates were on an a by mm and with as B; B; B; B; B; B. were at were from the and as previously described I.H. Downes C.P. Biochem. J. PubMed Scopus Google Scholar). were by of in and were in mm mm 1% 1 mm sodium mm mm mm sodium 1 1 mm and 1 mm were by at and for was and from with of cellular protein membranes and and the against the domain of and were as previously described M.R. A. der Kaay J. V. P. Biol. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar). PTEN antibodies were from was from Cell of as described by et al. T. F. L. A. J. Biol. Chem. 2002; Full Text Full Text PDF PubMed Scopus Google Scholar). were in was to cells in essential with at for to the of the the was and the were with essential with to The cells were for with acid at The acid was with in the and used to the of The cells were in 1 to the The of to was against was in the of of Cell cells were by in PBS, and in in were in plus 1% and for in plus and A. The of cells was a and fluorescence was on a and was used to Cell was colony were from described previously M.M. Kirsch K.H. T. T. Hanafusa H. Proc. Natl. Acad. Sci. U. S. A. 1999; 96: PubMed Scopus Google Scholar). U87-MG cells were with PTEN expression cells were in media with and and in in were for with the of of anchorage-dependent a was to that used by et al. H.J. Cancer Res. 1998; Google Scholar). U87-MG cells were and to with 1 Cell were at and to the previously expression of PTEN in U87-MG cells a in PtdInsP3 expression of PTEN the levels of expression in a in but not of and We have to levels of wild type and mutant PTEN to study the cellular of such protein with obtained from cells with PTEN that levels of expression of were comparable with the range of PTEN expression found in a of cell types We were to that cells were levels of protein the of these because this not previously been and these cells have levels of PtdInsP3 and PKB the levels of PtdIns(3)P, PtdIns(3,4)P2, and were not decreased Expression of levels of the mutant, PTEN and the lipid mutant, PTEN G129E phosphoprotein phosphatase PtdInsP3 It has been suggested that this is to in a the PtdInsP3 from by (3.Myers M.P. Pass I. Batty I.H. Van der Kaay J. Stolarov J.P. Hemmings B.A. Wigler M.H. Downes C.P. Tonks N.K. Proc. Natl. Acad. Sci. U. S. A. 1998; 95: 13513-13518Crossref PubMed Scopus (1013) Google Scholar). PTEN M-CBR3, PTEN and not inositol lipid levels of protein expression on inositol lipid levels in U87-MG cells in were with for was a cells were and in The was were and by are as of in the from for PTEN with are as of in the from for PTEN with in a new phosphate levels were the PTEN lowered Ins(1,3,4,5,6)P5 levels and However, because PTEN PTEN and PTEN the effects of PTEN expression, this to be to the activity of In PTEN M-CBR3 lowered Ins(1,3,4,5,6)P5 levels by 60% levels, and the levels of an inositol by 80%. the was not the of the 3-phosphatase activity of PTEN M-CBR3, Ins(1,4,5,6)P4, but was inositol the to Ins(1,3,4,5,6)P5 and of Ins(1,3,4,5,6)P5 by PTEN M-CBR3 in vitro Ins(1,4,5,6)P4, which was to indicating PTEN, PTEN M-CBR3 was as a 3-phosphatase not The of effect of PTEN that these effects are to the activity of PTEN and not mediated by phosphoprotein phosphatase activity of PTEN of protein expression on inositol phosphate levels in U87-MG cells in were with for was a cells were and in The was and inositol phosphates were by for inositol are as of in the from with with PTEN for are as of in the from with with with with with PTEN with for inositol are as of in the from for are as of in the from with with PTEN in a new PTEN M-CBR3 Ins(1,3,4,5,6)P5 levels without effect on inositol lipids, we have this mutant to roles of we Ins(1,3,4,5,6)P5 can regulate PKB phosphorylation, anchorage-independent colony cell clathrin-mediated internalization. Expression of PTEN M-CBR3 in U87-MG cells was unable to the phosphorylation of Expression of levels of wild type PTEN, which PtdInsP3 levels, a in and whereas receptor increased phosphorylation at suggest that Ins(1,3,4,5,6)P5 does not PKB phosphorylation with PtdInsP3 phosphorylation of In this respect, PKB to have a toward inositol than previously suggested H. T. F. H. U. M. M. PubMed Scopus Google Scholar, M. M. E. Hemmings B.A. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). with the substrate specificity of PTEN, in that inositol lipid can data with to because such studies to in the of a membrane phosphates, including Ins(1,3,4,5,6)P5, have been in of clathrin-mediated by of formation N. Shears S.B. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar, N. J.E. M. M.R. Mol. Google Scholar). was by of with U87-MG cells. of were PTEN M-CBR3 was U87-MG cells with at an kinase previously shown to receptor phosphorylation, and was found to as inhibiting not cellular processes have been identified that to some on phosphoinositide 3-kinase signaling and can be by PTEN, including colony formation in (10.Lee J.O. Yang H.J. Georgescu M.M. Di Cristofano A. Maehama T. Shi Y.G. Dixon J.E. Pandolfi P. Pavletich N.P. Cell. 1999; 99: 323-334Abstract Full Text Full Text PDF PubMed Scopus (883) Google Scholar, D.M. H. Proc. Natl. Acad. Sci. U. S. A. 1998; 95: PubMed Scopus Google and cell (12.Leslie N.R. Bennett D. Gray A. Pass I. Hoang-Xuan K. Downes C.P. Biochem. J. 2001; 357: 427-435Crossref PubMed Scopus (63) Google Scholar). The ability of PTEN M-CBR3 to anchorage-independent colony formation was with that of wild type U87-MG cells were with expression for PTEN a gene and into with with PTEN of PTEN colony but this was not by the PTEN PTEN PTEN PTEN M-CBR3 a but effect in colony its effects on anchorage-independent expression of PTEN lowered cellular proliferation as an effects were not by the PTEN PTEN PTEN PTEN M-CBR3, a but effect in proliferation that Ins(1,3,4,5,6)P5 plays a role in proliferation. The effects of PTEN on anchorage-independent growth and cellular proliferation to be mediated by its ability to The effects of PTEN M-CBR3 on cell-cycle were with expression for were by previously I.W. Vaillancourt M.T. J. A. Bookstein R. Cancer Res. 1998; Google PTEN an of cells in and a in the cells in of no to that Ins(1,3,4,5,6)P5 is not required to of the cell The roles of PTEN have been to its ability to metabolize the lipid PtdInsP3. it has been shown that PtdIns(3,5)P2, PtdIns(3,4)P2, and are substrates in vitro D. M.T. L. H. J. Biol. Chem. 2001; 276: Full Text Full Text PDF PubMed Scopus Google Scholar, S.M. Downes C.P. N.R. Biochem. J. 2001; PubMed Scopus Google Scholar). We show that the substrate for PTEN is PtdInsP3 and that the inositol lipid are not lowered PTEN expression at to physiological levels in U87-MG cells. levels of expression can regulate but not may the in of previously (4.McConnachie G. Pass I. Walker S.M. Downes C.P. Biochem. J. 2003; 371: 947-955Crossref PubMed Scopus (98) Google the of of these in this may the PtdInsP3 and such as and I. Liu D.M. 2000; 14: Google Scholar), whereas is to be of PtdInsP3. It has been shown that PTEN can dephosphorylate inositol phosphates in vitro, but their significance as physiological substrates has not been was shown to be a substrate than PtdInsP3 by a factor of and the of (4.McConnachie G. Pass I. Walker S.M. Downes C.P. Biochem. J. 2003; 371: 947-955Crossref PubMed Scopus (98) Google Scholar). Ins(1,3,4,5,6)P5 and are to be the substrates of a phosphatase, Indeed, studies and from were unable to Ins(1,3,4,5,6)P5 phosphatase activity in PTEN have been H. Yang X. J.E. Shears S.B. Mol. Cell. Biol. 2000; 20: PubMed Scopus Google Scholar), these were in the of a agent, required for activity of PTEN however, cellular Ins(1,3,4,5,6)P5 levels (16.Caffrey J.J. Darden T. Wenk M.R. Shears S.B. FEBS Lett. 2001; 499: 6-10Crossref PubMed Scopus (36) Google Scholar). In agreement with this we found that PTEN expression lowered Ins(1,3,4,5,6)P5 levels and but because these effects were expression of the inactive PTEN and the inactive PTEN G129E we that this effect is not mediated by the phosphatase activity of however, to expression of because the in Ins(1,3,4,5,6)P5 is not is We have previously found that inositol lipid by PTEN requires the C2 domain and that with this domain with the PTEN M-CBR3 lipid phosphatase activity but the activity a soluble substrate (4.McConnachie G. Pass I. Walker S.M. Downes C.P. Biochem. J. 2003; 371: 947-955Crossref PubMed Scopus (98) Google Scholar, 10.Lee J.O. Yang H.J. Georgescu M.M. Di Cristofano A. Maehama T. Shi Y.G. Dixon J.E. Pandolfi P. Pavletich N.P. Cell. 1999; 99: 323-334Abstract Full Text Full Text PDF PubMed Scopus (883) Google Scholar). We show that this mutant can Ins(1,3,4,5,6)P5 levels without effects on inositol inositol phosphates. We that levels of substrate of PTEN M-CBR3, are not can be by the of of and their The of by is more than that of The in levels is of a in Ins(1,3,4,5,6)P5 because the is to be the of cellular effects are mediated by the lipid activity of PTEN M-CBR3, because PTEN which its protein phosphatase activity activity toward inositol phosphates, was without suggests that Ins(1,3,4,5,6)P5 is a factor in cells and its is effects are without detectable effect on inositol PTEN M-CBR3 a Ins(1,3,4,5,6)P5 can be selectively has to some of the physiological roles that have been previously to The pleckstrin homology domains of many have been associated with the ability of these to with membrane Although the ability of a of these to bind inositol phosphates has been (see H. T. F. H. U. M. M. PubMed Scopus Google and J.M. Lee A. M. J. Biol. Chem. 1998; 273: Full Text Full Text PDF PubMed Scopus Google Scholar), it is recently that these have been to be inositol phosphates and inositol for domains is in the of phospholipase We were able to Ins(1,3,4,5,6)P5 has a role to in PKB We that was able to and that PTEN expression was able to the phosphorylation of PKB in these cells. of Ins(1,3,4,5,6)P5 levels expression of PTEN M-CBR3 was without effect on PKB phosphorylation, it is not a physiological regulator and is of with the lipid of this protein We have the effect of PTEN M-CBR3 expression on protein because Ins(1,3,4,5,6)P5 and have been to the of N. J.E. M. M.R. Mol. Google Scholar). The ability of Ins(1,3,4,5,6)P5 to formation in vitro has been to a particularly for N. Shears S.B. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). The of levels of is mediated by (see Ref. T. F. L. A. J. Biol. Chem. 2002; Full Text Full Text PDF PubMed Scopus Google Scholar). levels of that was to the receptor kinase and reduced The effects were not by lowering Ins(1,3,4,5,6)P5, that this inositol phosphate has no role to in of Our has been to that of for in which is into cells and the N. J.E. M. M.R. Mol. Google Scholar). We have the of PTEN M-CBR3 expression on inositol phosphate levels, whereas the of a inositol phosphate does not that it is not to with It that is to to The inositol phosphates, Ins(1,3,4,5,6)P5 and InsP6, have been in cell proliferation. of MIPP, by removal of the N-terminal sequence and the has been shown previously to Ins(1,3,4,5,6)P5 by and levels by and to a in the of cell proliferation H. Yang X. J.E. Shears S.B. Mol. Cell. Biol. 2000; 20: PubMed Scopus Google Scholar). It has been that the from proliferation to in is by the of identified as the homologue of C. J.E. Cell Res. PubMed Scopus Google Scholar). suggest that a reduction in cell growth with a reduction in the levels of Expression of PTEN M-CBR3 has been shown to proliferation of U87-MG (10.Lee J.O. Yang H.J. Georgescu M.M. Di Cristofano A. Maehama T. Shi Y.G. Dixon J.E. Pandolfi P. Pavletich N.P. Cell. 1999; 99: 323-334Abstract Full Text Full Text PDF PubMed Scopus (883) Google Scholar, 15.Georgescu M.M. Kirsch K.H. Kaloudis P. Yang H.J. Pavletich N.P. Hanafusa H. Cancer Res. 2000; 60: 7033-7038PubMed Google and cells M.M. Kirsch K.H. Kaloudis P. Yang H.J. Pavletich N.P. Hanafusa H. Cancer Res. 2000; 60: 7033-7038PubMed Google Scholar). We show that these effects with a in Ins(1,3,4,5,6)P5 without PtdInsP3 levels this suggest that Ins(1,3,4,5,6)P5 can growth of cells and as a proliferative PKB phosphorylation is not by PTEN M-CBR3 in of the studies PKB phosphorylation is to in PtdInsP3 X. Batty I.H. Downes C.P. J. Biol. Chem. 2002; Full Text Full Text PDF PubMed Scopus Google Scholar), this suggests that PtdInsP3 are not affected by PTEN M-CBR3, the that Ins(1,3,4,5,6)P5 is the in altering proliferation. The studies of anchorage-independent and anchorage-dependent proliferation the data as described of PTEN M-CBR3, which Ins(1,3,4,5,6)P5 levels, decreased colony and proliferation not to the as wild type Cell that the effects PTEN M-CBR3 are mediated by Ins(1,3,4,5,6)P5 and not by PtdInsP3. PTEN cells, more than cells, no in their cell In contrast, cells of have been that could for the effects of Ins(1,3,4,5,6)P5 levels on proliferation et al. E. F. K. J. Biol. Chem. Full Text PDF PubMed Google have previously shown that of Ins(1,3,4,5,6)P5 and with and suggested that of of Ins(1,3,4,5,6)P5 and is for the of cell could that reduction of Ins(1,3,4,5,6)P5 has X. H. R. Wu Wu C. 2003; PubMed Scopus Google Scholar), and this is the by which PTEN M-CBR3 proliferation. It is that of cells with toward levels whereas with to toward lowered Ins(1,3,4,5,6)P5 levels by J.M. G. J.A. Proc. R. B. Biol. Sci. PubMed Scopus Google Scholar). of whereas is and are required to these are mediated by In we have the effects of PTEN expression on inositol phosphate and inositol lipid levels and shown are to inositol lipids, PtdInsP3. PTEN does not a role in of inositol phosphates in We have that the PTEN M-CBR3 mutant Ins(1,3,4,5,6)P5 without PtdInsP3. PTEN M-CBR3 as a we that Ins(1,3,4,5,6)P5 plays no role in PKB phosphorylation receptor but plays a role in not as as PtdInsP3. PTEN M-CBR3 is a and regulator of Ins(1,3,4,5,6)P5 and can be used to the physiological roles played by this and inositol S. T. S. The and for R. G. C. The for

References

38